LEADER 01753oam  2200421   450 
001 9910707987303321
005 20170816162248.0
035   $a(CKB)5470000002468692
035   $a(OCoLC)968934049
035   $a(EXLCZ)995470000002468692
100   $a20170118d2016      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBioresearch labs and inactivation of dangerous pathogens $ehearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, September 27, 2016
210  1$aWashington :$cU.S. Government Publishing Office,$d2016.
215   $a1 online resource (iii, 99 pages)
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
300   $a"Serial No. 114-173."
320   $aIncludes bibliographical references.
517   $aBioresearch labs and inactivation of dangerous pathogens 
606   $aPathogenic microorganisms$xHandling$zUnited States$xSafety measures
606   $aMicrobial inactivation$xSafety measures
606   $aBiological laboratories$zUnited States$xSafety measures
608   $aLegislative hearings.$2lcgft
615  0$aPathogenic microorganisms$xHandling$xSafety measures.
615  0$aMicrobial inactivation$xSafety measures.
615  0$aBiological laboratories$xSafety measures.
801  0$bGPO
801  1$bGPO
801  2$bMERUC
801  2$bGPO
906   $aBOOK
912   $a9910707987303321
996   $aBioresearch labs and inactivation of dangerous pathogens$93475226
997   $aUNINA